Post-Kidney Transplant Erythrocytosis: Case Report

• DOI: 10.53855/bjt.v28i1.669_eng
• Publication Date: 2025-04-05T12:18:20Z
• Authors: Renato André Digieri; Américo Lourenço ...; Andréa Santos Galvão; Leonardo Victor B...; Precil Diego Mira...; Pedro Renato Chocair; Érico Souza de Ol...

We present the case report of a patient diagnosed with erythrocytosis after kidney transplantation, the occurrence of which must be known so that it can be accurately diagnosed and correctly treated, preserving patients from consequences related to blood hyperviscosity. It has several risk factors and can be asymptomatic or manifest in a typical form. The pathogenesis of erythrocytosis after kidney transplantation is multifactorial. The diagnosis is made in the appropriate clinical context, and other possible causes must necessarily be ruled out, some of which are potentially serious, such as proliferative diseases. The mainstay of treatment for erythrocytosis after kidney transplantation is the administration of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. With appropriate treatment, its prognosis is good.